Rhythm Pharmaceuticals, Inc.盘中异动快速下挫5.18%

自选股智能写手05-08

北京时间2024年05月08日21时35分，Rhythm Pharmaceuticals, Inc.（RYTM.us）股票出现异动，股价急速下挫5.18%。截至发稿，该股报37.31美元/股，成交量3.0275万股，换手率0.05%，振幅1.65%。最近的财报数据显示，该股实现营业收入25.97百万美元，净利润-1.41亿美元，每股收益-2.35美元，毛利23.16百万美元，市盈率-8.12倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2433172143?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-08 21:35","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2433172143","market":"us","top_or_hot":-1,"title":"Rhythm Pharmaceuticals, Inc.盘中异动 快速下挫5.18%","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年05月08日21时35分，Rhythm Pharmaceuticals, Inc.（RYTM.us）股票出现异动，股价急速下挫5.18%。截至发稿，该股报37.31美元/股，成交量3.0275万股，换手率0.05%，振幅1.65%。最近的财报数据显示，该股实现营业收入25.97百万美元，净利润-1.41亿美元，每股收益-2.35美元，毛利23.16百万美元，市盈率-8.12倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082135327a58c36d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rhythm Pharmaceuticals, Inc.盘中异动 快速下挫5.18%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRhythm Pharmaceuticals, Inc.盘中异动 快速下挫5.18%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-08 21:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082135327a58c36d&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年05月08日21时35分，Rhythm Pharmaceuticals, Inc.（RYTM.us）股票出现异动，股价急速下挫5.18%。截至发稿，该股报37.31美元/股，成交量3.0275万股，换手率0.05%，振幅1.65%。最近的财报数据显示，该股实现营业收入25.97百万美元，净利润-1.41亿美元，每股收益-2.35美元，毛利23.16百万美元，市盈率-8.12倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082135327a58c36d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082135327a58c36d&s=b","article_id":"2433172143","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082135327a58c36d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2433172143","pubTimestamp":1715175332,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年05月08日21时35分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.18%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。该信息摘要如下：Needham：维持Rhythm Pharmaceuticals评级，由买入调整至买入评级, 目标价由50.00美元调整至46.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4585":"ETF&股票定投概念","RYTM":"Rhythm Pharmaceuticals Inc.","BK4588":"碎股","BK4139":"生物科技"},"translate_title":"Rhythm Pharmaceuticals, Inc. fell 5.18% in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RYTM":0.9},"content_text":"北京时间2024年05月08日21时35分，Rhythm Pharmaceuticals, Inc.（RYTM.us）股票出现异动，股价急速下挫5.18%。截至发稿，该股报37.31美元/股，成交量3.0275万股，换手率0.05%，振幅1.65%。最近的财报数据显示，该股实现营业收入25.97百万美元，净利润-1.41亿美元，每股收益-2.35美元，毛利23.16百万美元，市盈率-8.12倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Adaptive Biotechnologies Corporation、Cel-Sci Corporation、内克塔治疗涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为203.94%、28.73%、12.45%，振幅较大的相关个股有Adaptive Biotechnologies Corporation、Y-Mabs Therapeutics, Inc.、Repare Therapeutics Inc.，振幅分别为15.27%、14.76%、10.06%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。公司专注于开发和商业化用于治疗胃肠道疾病和导致代谢紊乱的遗传缺陷的肽疗法。该公司的候选产品是setmelanotide (RM 493)，这是一种有效的黑素皮质素4或MC4受体激动剂，用于治疗由MC4通路缺陷引起的罕见遗传性肥胖疾病。从地理上看，该公司的收入来自美国、德国和其他国家，其中大部分来自美国。消息层面，截至21时35分，《Needham：维持Rhythm Pharmaceuticals(RYTM.US)评级，由买入调整至买入评级, 目标价由50.00美元调整至46.00美元。》资讯为影响Rhythm Pharmaceuticals, Inc.的重要信息。该信息摘要如下：Needham：维持Rhythm Pharmaceuticals(RYTM.US)评级，由买入调整至买入评级, 目标价由50.00美元调整至46.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2433172143"}

Rhythm Pharmaceuticals, Inc.盘中异动 快速下挫5.18%

精彩评论

Rhythm Pharmaceuticals, Inc.盘中异动快速下挫5.18%